Your browser doesn't support javascript.
loading
TC-N19, a novel dual inhibitor of EGFR and cMET, efficiently overcomes EGFR-TKI resistance in non-small-cell lung cancer cells.
Wu, D-W; Chen, T-C; Huang, H-S; Lee, H.
Afiliação
  • Wu DW; Graduate Institute of Cancer Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University, Taipei, Taiwan.
  • Chen TC; Graduate Institute of Cancer Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University, Taipei, Taiwan.
  • Huang HS; Graduate Institute of Cancer Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University, Taipei, Taiwan.
  • Lee H; Graduate Institute of Cancer Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University, Taipei, Taiwan.
Cell Death Dis ; 7(6): e2290, 2016 06 30.
Article em En | MEDLINE | ID: mdl-27362807

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 6_ODS3_enfermedades_notrasmisibles Base de dados: MEDLINE Assunto principal: Antraquinonas / Carcinoma Pulmonar de Células não Pequenas / Resistencia a Medicamentos Antineoplásicos / Proteínas Proto-Oncogênicas c-met / Inibidores de Proteínas Quinases / Receptores ErbB / Neoplasias Pulmonares Limite: Animals / Humans Idioma: En Revista: Cell Death Dis Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 6_ODS3_enfermedades_notrasmisibles Base de dados: MEDLINE Assunto principal: Antraquinonas / Carcinoma Pulmonar de Células não Pequenas / Resistencia a Medicamentos Antineoplásicos / Proteínas Proto-Oncogênicas c-met / Inibidores de Proteínas Quinases / Receptores ErbB / Neoplasias Pulmonares Limite: Animals / Humans Idioma: En Revista: Cell Death Dis Ano de publicação: 2016 Tipo de documento: Article